Peptide targeting and imaging of damaged lung tissue in influenza-infected mice

Future Microbiology

Volumn 8, Issue 2, 2013, Pages 257-269

  Li, Na ^a,b   Yin, Lu ^a   Thévenin, Damien ^c   Yamada, Yoshiyuki ^a   Limmon, Gino ^a   Chen, Jianzhu ^d   Chow, Vincent T K ^b   Engelman, Donald M ^c   Engelward, Bevin P ^e  

^a SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c YALE UNIVERSITY   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e USA   (United States)

Author keywords

delivery; inflammation; influenza; peptide; pHLIP

Indexed keywords

PEPTIDE; PEROXIREDOXIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONJUGATE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; HISTOLOGY; INFLAMMATORY INFILTRATE; INFLUENZA A (H1N1); LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG INFILTRATE; LUNG INJURY; LUNG PARENCHYMA; MOLECULAR IMAGING; MOUSE; NONHUMAN; PH; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCYTOCHEMISTRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INJECTIONS, INTRAPERITONEAL; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PROTEIN TRANSPORT;

EID: 84873333450     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.134     Document Type: Article

References (43)

1. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 85(2), 85-92 (2007). (Pubitemid 46398724)
2. Howard WA, Peiris M, Hayden FG. Report of the 'Mechanisms of Lung Injury and Immunomodulator Interventions in Influenza' workshop, 21 March 2010, Ventura, California, USA. Influenza Other Respi. Viruses 5(6), 453-454, e458-e475 (2011).
3. Andreev OA, Dupuy AD, Segala M et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc. Natl Acad. Sci. USA 104(19), 7893-7898 (2007). (Pubitemid 47185847)
4. Segala J, Engelman DM, Reshetnyak YK, Andreev OA. Accurate analysis of tumor margins using a fluorescent pH low insertion peptide (pHLIP). Int. J. Mol. Sci. 10(8), 3478-3487 (2009).
5. Andreev OA, Engelman DM, Reshetnyak YK. Targeting acidic diseased tissue: new technology based on use of the pH (low) insertion peptide (pHLIP). Chim. Oggi 27(2), 34-37 (2009).
6. Reshetnyak YK, Yao L, Zheng S, Kuznetsov S, Engelman DM, Andreev OA. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Mol. Imaging Biol. 13(6), 1146-1156 (2011).
7. Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc. Natl Acad. Sci. USA 103(17), 6460-6465 (2006).
8. An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM. pH-(low)- insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proc. Natl Acad. Sci. USA 107(47), 20246-20250 (2010).
9. Thevenin D, An M, Engelman DM. pHLIP-mediated translocation of membrane-impermeable molecules into cells. Chem. Biol. 16(7), 754-762 (2009).
10. Punnia-Moorthy A. Evaluation of pH changes in inflammation of the subcutaneous air pouch lining in the rat, induced by carrageenan, dextran and Staphylococcus aureus. J. Oral Pathol. 16(1), 36-44 (1987).
11. Martin GR, Jain RK. Fluorescence ratio imaging measurement of pH gradients: calibration and application in normal and tumor tissues. Microvasc. Res. 46(2), 216-230 (1993).
12. Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L. Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus Y United States, 2009. Clin. Infect. Dis. 54(9), 1221-1229 (2012).
13. Buchweitz JP, Harkema JR, Kaminski NE. Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35(3), 424-435 (2007).
14. Srivastava B, Blazejewska P, Hessmann M et al. Host genetic background strongly influences the response to influenza A virus infections. PLoS One 4(3), e4857 (2009).
15. Yamada Y, Limmon GV, Zheng D et al. Major shifts in the spatioYtemporal distribution of lung antioxidant enzymes during influenza pneumonia. PLoS One 7(2), e31494 (2012).
16. Kumar PA, Hu Y, Yamamoto Y et al. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147(3), 525-538 (2011).
17. Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc. Natl Acad. Sci. USA 107(9), 4081-4086 (2010).
18. Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc. Natl Acad. Sci. USA 105(40), 15340-15345 (2008).
19. Narasaraju T, Ng HH, Phoon MC, Chow VT. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am. J. Respir. Cell Mol. Biol. 42(6), 732-743 (2010).
20. Perl M, Lomas-Neira J, Chung CS, Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury Y a unifying hypothesis? What we have learned from small interfering RNAs. Mol. Med. 14(7-8), 465-475 (2008).
21. Smani Y, Docobo-Perez F, McConnell MJ, Pachon J. Acinetobacter baumannii-induced lung cell death: role of inflammation, oxidative stress and cytosolic calcium. Microb. Pathog. 50(5), 224-232 (2011).
22. Rock KL. Pathobiology of inflammation to cell death. Biol. Blood Marrow Transplant. 15(1 Suppl.), 137-138 (2009).
23. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect. Immun. 66(3), 912-922 (1998). (Pubitemid 28101126)
24. Fisher AB. Peroxiredoxin 6: A bifunctional enzyme with glutathione peroxidase and phospholipase A activities. Antioxid. Redox Signal. 15(3), 831-844 (2011).
25. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am. J. Respir. Cell Mol. Biol. 34(4), 481-486 (2006).
26. Yang D, Song Y, Wang X et al. Deletion of peroxiredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice. Crit. Care Med. 39(4), 756-764 (2011).
27. Nicolini A, Ferrera L, Rao F, Senarega R, Ferrari-Bravo M. Chest radiological findings of influenza A H1N1 pneumonia. Rev. Port. Pneumol. 18(3), 120-127 (2012).
28. Menkin V. Biochemical mechanisms in inflammation. BMJ 1(5185), 1521-1528 (1960).
29. Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J. Immunol. 172(8), 4661-4665 (2004). (Pubitemid 38456383)
30. Daumar P, Wanger-Baumann CA, Pillarsetty N et al. Efficient 18F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjug. Chem. 23(8), 1557-1566 (2012).
31. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J. Biol. Chem. 268(28), 21212-21217 (1993). (Pubitemid 23292309)
32. Rennard SI, Wachenfeldt K. Rationale and emerging approaches for targeting lung repair and regeneration in the treatment of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 8(4), 368-375 (2011).
33. Liu G, Feinstein SI, Wang Y et al. Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against oxidative stress in the mouse lung. Free Radic. Biol. Med. 49(7), 1172-1181 (2010).
34. Imai Y, Kuba K, Neely GG et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133(2), 235-249 (2008). (Pubitemid 351512299)
35. Wuttge DM, Bruzelius M, Stemme S. T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology 98(2), 273-279 (1999). (Pubitemid 29487650)
36. Wu YZ, Manevich Y, Baldwin JL et al. Interaction of surfactant protein A with peroxiredoxin 6 regulates phospholipase A2 activity. J. Biol. Chem. 281(11), 7515-7525 (2006). (Pubitemid 43847522)
37. Manevich Y, Shuvaeva T, Dodia C, Kazi A, Feinstein SI, Fisher AB. Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A2 activities. Arch. Biochem. Biophys. 485(2), 139-149 (2009).
38. Valente T, Lassandro F, Marino M, Squillante F, Aliperta M, Muto R. H1N1 pneumonia: our experience in 50 patients with a severe clinical course of novel swine-origin influenza A (H1N1) virus (S-OIV). Radiol. Med. 117(2), 165-184 (2012).
39. Soepandi PZ, Burhan E, Mangunnegoro H et al. Clinical course of avian influenza A(H5N1) in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest 138(3), 665-673 (2010).
40. Bay A, Etlik O, Oner AF et al. Radiological and clinical course of pneumonia in patients with avian influenza H5N1. Eur. J. Radiol. 61(2), 245-250 (2007). (Pubitemid 46096693)
41. Nakajima N, Sato Y, Katano H et al. Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod. Pathol. 25(1), 1-13 (2012).
42. Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol. 172(5), 1155-1170 (2008). (Pubitemid 351671530)
43. Korotzer TI, Weiss HS, Hamparian VV, Somerson NL. Oxygen uptake and lung function in mice infected with Streptococcus pneumoniae, influenza virus, or Mycoplasma pulmonis. J. Lab. Clin. Med. 91(2), 280-294 (1978). (Pubitemid 8273774)